The Institut Galien Paris-Saclay (UMR CNRS 8612), founded in 1986, develops micro- and nanotechnologies for drug delivery and diagnostics in the field of health. A distinctive feature of the unit is its interdisciplinary structure, bringing together researchers and academics from diverse backgrounds including chemistry, physical chemistry, pharmaceutics, analytical chemistry, and biology.

The research activities are structured around four major scientific challenges:

  1. Overcoming physiological barriers

  2. Designing smart, programmable, activatable, and biocompatible materials

  3. Developing predictive models for the formation of new objects and their transport across biological barriers (tissue, cellular, and subcellular)

  4. Advancing diagnostic and imaging techniques through chemistry, physical chemistry, and formulation science

To address these challenges, the Institut Galien Paris-Saclay relies on four state-of-the-art technological platforms: nano-object characterisation, biology, analytics, and biophysics & instrumentation. The institute’s international visibility is reflected in its ability to attract a large number of PhD students and postdoctoral researchers from around the world.

The unit is home to four members of the Institut Universitaire de France, one ERC grant holder, five members of the French National Academy of Pharmacy, and one member of the French Academy of Sciences.

We recently moved to a new building on the Henri Moissan site, located on the Plateau de Moulon in Orsay. This relocation brings us closer to several other research units and further strengthens our contribution to the international reputation of Université Paris-Saclay and the CNRS in pharmaceutical sciences.

Prof. Myriam Taverna